MENU
TVGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tevogen Bio Holdings (TVGN) Ownership - Who owns Tevogen Bio Holdings?
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders... Show more
Profile
Industry
N/A
Address
15 Independence Boulevard
Phone
N/A
Employees
N/A
Web
https://www.tevogen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
226.19M
P/E Ratio
2.88
Total Cash
2.33M
Projected Growth
N/A
Total Debt
2.96M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TVGN
Capitalization
226M
P/E Ratio
2.88
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.33M
Total Cash/Share
0.01
Total Debt
2.97M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-12.99M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.1K
Current Ratio
0.34
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
52.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
1303.51
Shares Held By Institutions
4.45M
Shares Outstanding - Current
184M
Total Liabilities
10.5M
Total Volume MTD
N/A
Value
1
Gain YTD
19.417
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
15 Independence Boulevard
Phone
N/A
Employees
N/A
Web
https://www.tevogen.com